Gupta Suneel

CIK 00017639231 companyNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001763923

Recent Transactions

36 trades

Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-11-26−30,000→ 93,750 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-26$12.17/sh+30,000→ 286,174 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-26$45.50/sh−19,191→ 266,983 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-26$12.17/sh+450→ 267,433 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-11-26−450→ 93,300 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-11-25−45,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-25$7.38/sh+45,000→ 229,611 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-25$7.80/sh+85,000→ 359,611 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-11-25−85,000→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-25$46.04/sh−103,437→ 256,174 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-11-25−45,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-11-25$8.02/sh+45,000→ 274,611 total
Tax Payment
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-02-26$29.53/sh−4,282→ 183,285 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-01-09$25.00/sh−5,000→ 187,567 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-09−5,000→ 45,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-01-09$7.38/sh+5,000→ 192,567 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+71,500→ 71,500 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-01-02+19,250→ 187,567 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2023-10-19$7.38/sh+20,000→ 168,317 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-10-19−20,000→ 50,000 total
Tax Payment
Protagonist Therapeutics, Inc$PTGX
Common Stock
2023-05-31$26.07/sh−4,150→ 148,037 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2023-05-31+12,000→ 152,187 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2023-01-16+20,625→ 138,187 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+123,750→ 123,750 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2022-04-26$7.38/sh+40,000→ 117,561 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-04-26−40,000→ 70,000 total
Tax Payment
Protagonist Therapeutics, Inc$PTGX
Common Stock
2022-02-28$24.28/sh−649→ 77,007 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2022-02-15+12,500→ 77,656 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-02-15+75,000→ 75,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-26+12,000→ 63,987 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-02-26+80,000→ 80,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-02-28+85,000→ 85,000 total
Purchase
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-12-03$5.13/sh+30,000→ 49,500 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-02-28+7,500→ 17,500 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-02-28+45,000→ 45,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-01-15+110,000→ 110,000 total

Companies

Protagonist Therapeutics, Inc
EVP Clinical Operations
$PTGX

Recent Filings

Address

7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560

View on SEC.gov